标题
Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume 47, Issue 1, Pages 7-18
出版商
Wiley
发表日期
2016-11-21
DOI
10.1111/eci.12695
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nuclear receptors and nonalcoholic fatty liver disease 1 1This article is part of a Special Issue entitled: Xenobiotic nuclear receptors: New Tricks for An Old Dog, edited by Dr. Wen Xie.
- (2016) Matthew C. Cave et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis
- (2016) Elisabeth M. Meier et al. CYTOKINE
- Annexin A6 protein is downregulated in human hepatocellular carcinoma
- (2016) Elisabeth M. Meier et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Adipocyte-secreted chemerin is processed to a variety of isoforms and influences MMP3 and chemokine secretion through an NFkB-dependent mechanism
- (2016) Helen J. Dranse et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Hepatic scavenger receptor BI is associated with type 2 diabetes but unrelated to human and murine non-alcoholic fatty liver disease
- (2015) Lisa Rein-Fischboeck et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Reduced serum chemerin in patients with more severe liver cirrhosis
- (2015) Kristina Eisinger et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: A critical role for IL-6/STAT3
- (2015) Ming-Jiang Xu et al. HEPATOLOGY
- Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease
- (2015) Shweta Kapil et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Chenodeoxycholic acid, an endogenous FXR ligand alters adipokines and reverses insulin resistance
- (2015) Mohamed Sham Shihabudeen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases
- (2015) Fangfang Zhang et al. MOLECULAR ENDOCRINOLOGY
- Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity
- (2015) M G M Wolfs et al. Nutrition & Diabetes
- Practice patterns in NAFLD and NASH: real life differs from published guidelines
- (2015) Mary E. Rinella et al. Therapeutic Advances in Gastroenterology
- Pathological Features of Fatty Liver Disease
- (2014) Matthew M. Yeh et al. GASTROENTEROLOGY
- Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution
- (2014) Masato Yoneda et al. HEPATOLOGY RESEARCH
- Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease
- (2014) Zi Ye et al. MOLECULAR BIOLOGY REPORTS
- Chemerin Induces Insulin Resistance in Rat Cardiomyocytes in Part through the ERK1/2 Signaling Pathway
- (2014) Ruining Zhang et al. PHARMACOLOGY
- Association between Serum Chemerin Concentrations and Clinical Indices in Obesity or Metabolic Syndrome: A Meta-Analysis
- (2014) Ya Li et al. PLoS One
- HepaticChemerinandChemokine-Like Receptor 1Expression in Patients with Chronic Hepatitis C
- (2014) Michał Kukla et al. Biomed Research International
- Identification of Chemerin as a Novel FXR Target Gene Down-Regulated in the Progression of Nonalcoholic Steatohepatitis
- (2013) Yujie Deng et al. ENDOCRINOLOGY
- Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease
- (2013) S Döcke et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver
- (2013) Sabrina Krautbauer et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Human parenchymal and non-parenchymal liver cell isolation, culture and characterization
- (2013) Georg Damm et al. Hepatology International
- Oxidative stress mediates chemerin-induced autophagy in endothelial cells
- (2012) Weili Shen et al. FREE RADICAL BIOLOGY AND MEDICINE
- NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
- (2012) Geoffrey C. Farrell et al. Gut and Liver
- Lipocalin 2 Deficiency Dysregulates Iron Homeostasis and Exacerbates Endotoxin-Induced Sepsis
- (2012) G. Srinivasan et al. JOURNAL OF IMMUNOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Towards an integrative approach to understanding the role of chemerin in human health and disease
- (2012) J. L. Rourke et al. Obesity Reviews
- Association of chemerin levels in synovial fluid with the severity of knee osteoarthritis
- (2011) Ke Huang et al. BIOMARKERS
- Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?
- (2011) Christa Buechler et al. CURRENT DRUG METABOLISM
- Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro
- (2011) Sabrina Bauer et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes
- (2010) Josef Wanninger et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Expression of Human Chemerin Induces Insulin Resistance in the Skeletal Muscle but Does Not Affect Weight, Lipid Levels, and Atherosclerosis in LDL Receptor Knockout Mice on High-Fat Diet
- (2010) M. Becker et al. DIABETES
- Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes
- (2010) Matthew C. Ernst et al. ENDOCRINOLOGY
- Sterol Regulatory Element-Binding Protein 2 (SREBP2) Activation after Excess Triglyceride Storage Induces Chemerin in Hypertrophic Adipocytes
- (2010) Sabrina Bauer et al. ENDOCRINOLOGY
- Neutrophil Gelatinase-Associated Lipocalin and Hepcidin: What Do They Have in Common and Is There a Potential Interaction?
- (2010) Jolanta Malyszko et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Serum chemerin and vaspin in non-alcoholic fatty liver disease
- (2010) Michal Kukla et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease
- (2010) Yusuf Yilmaz et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Chemerin: at the crossroads of inflammation and obesity
- (2010) Matthew C. Ernst et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin
- (2009) B. K. Tan et al. DIABETES
- Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells
- (2009) Henrike Sell et al. DIABETES
- Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model
- (2009) S. Luangsay et al. JOURNAL OF IMMUNOLOGY
- Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
- (2008) David Preiss et al. CLINICAL SCIENCE
- Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease
- (2008) Nobito Higuchi et al. HEPATOLOGY RESEARCH
- Synthetic chemerin-derived peptides suppress inflammation through ChemR23
- (2008) Jenna L. Cash et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adipocytokines and liver disease
- (2008) Yoshihiro Kamada et al. JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started